Similar articles for PMID: 27354603

Year	Number of Results
2000	1
2003	1
2006	1
2007	1
2008	1
2009	3
2010	2
2011	4
2012	9
2013	6
2014	12
2015	19
2016	11
2017	9
2018	4
2019	3
2020	3
2021	2
2022	3
2024	0

1

Cancer Stem Cell Properties as Factors Predictive of Chemoresistance in Neoadjuvantly-treated Patients with Ovarian Cancer.

Pylväs-Eerola M, Liakka A, Puistola U, Koivunen J, Karihtala P. Pylväs-Eerola M, et al. Anticancer Res. 2016 Jul;36(7):3425-31. Anticancer Res. 2016. PMID: 27354603

2

Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.

Ayub TH, Keyver-Paik MD, Debald M, Rostamzadeh B, Thiesler T, Schröder L, Barchet W, Abramian A, Kaiser C, Kristiansen G, Kuhn W, Kübler K. Ayub TH, et al. Oncotarget. 2015 Jun 30;6(18):16437-48. doi: 10.18632/oncotarget.4103. Oncotarget. 2015. PMID: 25999351 Free PMC article.

3

Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S. Tanei T, et al. Clin Cancer Res. 2009 Jun 15;15(12):4234-41. doi: 10.1158/1078-0432.CCR-08-1479. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509181

4

Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.

Ruscito I, Cacsire Castillo-Tong D, Vergote I, Ignat I, Stanske M, Vanderstichele A, Ganapathi RN, Glajzer J, Kulbe H, Trillsch F, Mustea A, Kreuzinger C, Benedetti Panici P, Gourley C, Gabra H, Kessler M, Sehouli J, Darb-Esfahani S, Braicu EI. Ruscito I, et al. Eur J Cancer. 2017 Jul;79:214-225. doi: 10.1016/j.ejca.2017.04.016. Epub 2017 May 16. Eur J Cancer. 2017. PMID: 28525846 Free article.

5

The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.

Davidson B, Holth A, Hellesylt E, Tan TZ, Huang RY, Tropé C, Nesland JM, Thiery JP. Davidson B, et al. Hum Pathol. 2015 Jan;46(1):1-8. doi: 10.1016/j.humpath.2014.10.004. Epub 2014 Oct 16. Hum Pathol. 2015. PMID: 25455994

6

ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome.

Wang YC, Yo YT, Lee HY, Liao YP, Chao TK, Su PH, Lai HC. Wang YC, et al. Am J Pathol. 2012 Mar;180(3):1159-1169. doi: 10.1016/j.ajpath.2011.11.015. Epub 2012 Jan 2. Am J Pathol. 2012. PMID: 22222226 Free article.

7

Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.

Xie Q, Liang J, Rao Q, Xie X, Li R, Liu Y, Zhou H, Han J, Yao T, Lin Z. Xie Q, et al. Ann Surg Oncol. 2016 Jan;23(1):163-70. doi: 10.1245/s10434-015-4555-7. Epub 2015 Apr 28. Ann Surg Oncol. 2016. PMID: 25916979

8

Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.

Liu Y, Yasukawa M, Chen K, Hu L, Broaddus RR, Ding L, Mardis ER, Spellman P, Levine DA, Mills GB, Shmulevich I, Sood AK, Zhang W. Liu Y, et al. JAMA Oncol. 2015 Jul;1(4):486-94. doi: 10.1001/jamaoncol.2015.1432. JAMA Oncol. 2015. PMID: 26181259 Free PMC article.

9

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.

Zanotti L, Romani C, Tassone L, Todeschini P, Tassi RA, Bandiera E, Damia G, Ricci F, Ardighieri L, Calza S, Marchini S, Beltrame L, Tognon G, D'Incalci M, Pecorelli S, Sartori E, Odicino F, Ravaggi A, Bignotti E. Zanotti L, et al. BMC Cancer. 2017 May 25;17(1):366. doi: 10.1186/s12885-017-3334-1. BMC Cancer. 2017. PMID: 28545541 Free PMC article.

10

Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma.

Bonneau C, Rouzier R, Geyl C, Cortez A, Castela M, Lis R, Daraï E, Touboul C. Bonneau C, et al. Gynecol Oncol. 2015 Jan;136(1):112-20. doi: 10.1016/j.ygyno.2014.10.024. Epub 2014 Nov 1. Gynecol Oncol. 2015. PMID: 25449309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year